Active Studies

The University of Kansas
Medical Center is looking for women in the Kansas City area to
participate in a study highlighting the reproductive experiences of Black women dealing with infertility.

The purpose of this study is to evaluate whether axicabtagene ciloleucel therapy improves the
clinical outcome compared with standard of care second-line therapy in patients with
relapsed/refractory DLBCL.

The purpose of this study is to find a dose of hydralazine that would be best to treat patient with ADPKD

University of Kansas researchers are conducting a study about how young people's brains respond to advertising images.

Phase 1: You will answer two short surveys and go through a brain imaging scan (fMRI) while seeing advertising images and messaging. fMRI does not use radiation and is approved by the FDA.

Phase 2: You will have a one-week follow-up via phone or an online survey. You will be compensated $115 (Phase 1: $80 and Phase 2: $35) for being in the study.

WHAT: Are you between 14 and 18? Do you have a child between 14 and 18? 

This is a Phase 1, double-blind, placebo-controlled, single ascending dose cohort study to
evaluate the safety, tolerability, and plasma concentrations of WVE-210201 in ambulatory and
non-ambulatory male pediatric patients with DMD amenable to exon 51 skipping intervention.